Skip to content
  • Saturday, 15 August 2026
  • 12:22 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • European Biotech Leaders Chart Course for Innovation, Urge Risk-Taking and Long-Term Commitment at Millennium Technology Prize Panel
Biotech & Genetic Research

European Biotech Leaders Chart Course for Innovation, Urge Risk-Taking and Long-Term Commitment at Millennium Technology Prize Panel

Jia Lissa May 19, 2026 0

A recent high-level panel discussion, convened by the Technology Academy Finland (TAF) and hosted at the residence of the Finnish…

Read More
Pharmaceutical R&D

Biopharma Leaders Urge Dr. Richard Pazdur to Lead FDA Amidst Crisis of Confidence

Teuku Ryan May 15, 2026 0

The leadership void at the U.S. Food and Drug Administration (FDA) has prompted a significant groundswell of support from the…

Read More
UCSF Researchers Uncover Biological Circuit Linking Gut Immune Response to Brain Signaling and Appetite Suppression During Parasitic InfectionDecoding the Inflammatory Landscape of the Bone Marrow Niche and Its Role in the Pathogenesis of Myeloid MalignanciesBreast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.Arctic Enigma: DNA Unlocks Beluga Whale Family Secrets in Bristol Bay
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ